Reimagining Health as a 'Flow on Effect' of Biomedical Innovation: Research Policy as a Site of State Activism

As health care systems have been recast as innovation assets, commercial aims are increasingly prominent within states' health and medical research policies. Despite this, the reformulation of notions of social and of scientific value and of long-standing relations between science and the state that is occurring in research policies remains comparatively unexamined. Addressing this lacuna, this article investigates the articulation of 'actually existing neoliberalism' in research policy by examining a major Australian research policy and funding instrument, the Medical Research Future Fund (MRFF). We identify the MRFF and allied initiatives as a site of state activism: reallocating resources from primary and preventive health care to commercially-oriented biomedical research; privileging commercial objectives in research and casting health as a flow on effect; reorganising the publicly funded production of health and medical knowledge; and arrogating for political actors a newly prominent role in research grant assessment and funding allocation. We conclude that rather than the state's assumption of a more activist role in medical research and innovation straightforwardly serving a 'public good', it is a driver of neoliberalisation that erodes commitments to redistributive justice in health care and significantly reconfigures science-state relations in research policy.

Automated summary

This article investigates the manifestation of "actually existing neoliberalism" in research policy through examining a major Australian research policy and funding instrument, the Medical Research Future Fund (MRFF). The study finds that the MRFF reallocates resources from primary and preventive health care to commercially-oriented biomedical research, prioritizes commercial objectives, reorganizes the production of publicly funded health and medical knowledge, and gives political actors a prominent role in research grant assessment and funding allocation. The conclusion suggests that the state's more activist role in medical research and innovation drives neoliberalization, eroding commitments to redistributive justice in healthcare and significantly reshaping science-state relations in research policy.